The effect of altitude on the expression of immune-related genes in Peruvian rural indigenous

Jaramillo-Valverde, L.; de Araujo, G. S.; Poterico, J. A.; Martinez-Jaramillo, C.; Roa-Linares, V.; Alvites-Arrieta, S.; Pablo-Ramirez, N.; Ubillus, M.; Palma-Lozano, D.; Silva-Carvalho, C.; Vasconcelos-da-Gama, L.; Costa, L. F.; Tarazona-Santos, E.; Raychaudhuri, S.; Guio, H.

doi:10.1101/2024.03.06.583674

bioRxiv · 10.1101/2024.03.06.583674

The effect of altitude on the expression of immune-related genes in Peruvian rural indigenous

Jaramillo-Valverde, L.·de Araujo, G. S.·Poterico, J. A.·Martinez-Jaramillo, C.·Roa-Linares, V.·Alvites-Arrieta, S.·Pablo-Ramirez, N.·Ubillus, M.·Palma-Lozano, D.·Silva-Carvalho, C.·Vasconcelos-da-Gama, L.·Costa, L. F.·Tarazona-Santos, E.·Raychaudhuri, S.·Guio, H.

View original source ↗Export metadata ↓

Abstract

BackgroundGenetic factors influencing immune response pathways in Andean populations may underlie adaptations to high-altitude environments. To investigate transcriptomic signatures associated with altitude, we analyzed immune-related gene expression across individuals residing at different elevations. MethodsWe recruited 62 Peruvian volunteers, predominantly from rural regions with high proportions of indigenous ancestry, living at low and high altitudes. Peripheral blood mononuclear cells (PBMCs) were stimulated with bacterial lipopolysaccharide (LPS), Pam3CSK4 (a synthetic triacylated lipopeptide), and R848 (an imidazoquinoline analog of viral nucleic acids). Population structure and ancestry were characterized, and transcriptome-wide differential expression analyses were performed. ResultsWe identified 30 genes with significant altitude-associated expression differences, including 22 downregulated (e.g., FN1, CD36, FOS) and nine upregulated genes. Functional enrichment indicated roles in acute inflammatory response, leukocyte migration, and positive regulation of myeloid leukocyte differentiation. ConclusionsHigh- and low-altitude Andean individuals exhibit distinct immune gene expression profiles, defining a population-specific transcriptomic signature that may reflect altitude-related immune adaptation. AUTHOR SUMMARYAndean populations exhibit genetic adaptations in immune response pathways, potentially linked to high-altitude living. To investigate this, we conducted genome-wide and transcriptome-wide analyses to identify immune-related gene expression differences between high- and low-altitude residents. We analyzed the genetic structure and ancestry of Peruvian individuals (primarily rural, with strong indigenous ancestry) living at different altitudes. Peripheral blood mononuclear cells (PBMCs) from 62 volunteers were stimulated with bacterial (LPS, Pam3CSK4) and viral (R848) mimics to assess immune responses. Differential expression analysis identified 22 down-regulated genes (e.g., FN1, CD36, FOS) and nine up-regulated genes, enriched in acute inflammatory response, leukocyte migration, and myeloid leukocyte differentiation. Our findings reveal a unique immune gene expression profile in Andean highlanders, distinct from other populations, suggesting adaptive modulation of both innate and adaptive immunity in response to high-altitude challenges.

Explore related subjects

genetics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Jaramillo-Valverde, L., de Araujo, G. S., Poterico, J. A., Martinez-Jaramillo, C., Roa-Linares, V., Alvites-Arrieta, S., Pablo-Ramirez, N., Ubillus, M., Palma-Lozano, D., Silva-Carvalho, C., Vasconcelos-da-Gama, L., Costa, L. F., Tarazona-Santos, E., Raychaudhuri, S., Guio, H.. 2024-03-11. The effect of altitude on the expression of immune-related genes in Peruvian rural indigenous. https://doi.org/10.1101/2024.03.06.583674

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗